Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ketamine | 11 | 2024 | 524 | 4.690 |
Why?
|
Bipolar Disorder | 31 | 2023 | 5124 | 4.400 |
Why?
|
Electroconvulsive Therapy | 10 | 2024 | 502 | 3.230 |
Why?
|
Depressive Disorder, Major | 23 | 2023 | 4816 | 2.960 |
Why?
|
Antidepressive Agents | 9 | 2023 | 2913 | 1.470 |
Why?
|
Lithium | 5 | 2023 | 600 | 1.350 |
Why?
|
Amygdala | 7 | 2018 | 1382 | 1.250 |
Why?
|
Emotions | 9 | 2020 | 2773 | 1.090 |
Why?
|
Facial Expression | 5 | 2020 | 515 | 0.880 |
Why?
|
Reflex Sympathetic Dystrophy | 2 | 2013 | 60 | 0.790 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2017 | 419 | 0.790 |
Why?
|
Lithium Compounds | 4 | 2023 | 226 | 0.780 |
Why?
|
Dopamine Agents | 2 | 2013 | 190 | 0.760 |
Why?
|
Memantine | 2 | 2013 | 111 | 0.760 |
Why?
|
Depression | 13 | 2023 | 8235 | 0.720 |
Why?
|
Triazines | 2 | 2013 | 312 | 0.700 |
Why?
|
Corpus Striatum | 4 | 2016 | 1238 | 0.680 |
Why?
|
Brain | 19 | 2022 | 27438 | 0.660 |
Why?
|
Affective Symptoms | 2 | 2018 | 418 | 0.640 |
Why?
|
Magnetic Resonance Imaging | 28 | 2022 | 36840 | 0.630 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2020 | 6035 | 0.610 |
Why?
|
Analgesics | 3 | 2020 | 1070 | 0.600 |
Why?
|
Nerve Net | 4 | 2018 | 2362 | 0.590 |
Why?
|
Antimanic Agents | 4 | 2023 | 524 | 0.590 |
Why?
|
Transsexualism | 1 | 2020 | 210 | 0.540 |
Why?
|
Sertraline | 3 | 2007 | 209 | 0.490 |
Why?
|
Cerebral Cortex | 5 | 2016 | 5827 | 0.490 |
Why?
|
Impulsive Behavior | 1 | 2017 | 350 | 0.460 |
Why?
|
Brain Mapping | 10 | 2020 | 6740 | 0.450 |
Why?
|
Anticonvulsants | 3 | 2020 | 1923 | 0.420 |
Why?
|
Neural Pathways | 6 | 2018 | 3122 | 0.410 |
Why?
|
Limbic System | 3 | 2009 | 423 | 0.380 |
Why?
|
Prefrontal Cortex | 3 | 2017 | 2251 | 0.370 |
Why?
|
Creatine | 1 | 2013 | 427 | 0.370 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2015 | 302 | 0.370 |
Why?
|
Rest | 1 | 2016 | 952 | 0.370 |
Why?
|
Anxiety Disorders | 3 | 2020 | 2754 | 0.360 |
Why?
|
Humans | 71 | 2024 | 768451 | 0.330 |
Why?
|
Adult | 39 | 2024 | 223542 | 0.330 |
Why?
|
Affect | 3 | 2007 | 1498 | 0.320 |
Why?
|
Models, Neurological | 2 | 2016 | 1784 | 0.310 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2017 | 9066 | 0.300 |
Why?
|
Executive Function | 1 | 2017 | 1402 | 0.300 |
Why?
|
Lactic Acid | 1 | 2013 | 1140 | 0.300 |
Why?
|
Pattern Recognition, Visual | 1 | 2013 | 825 | 0.280 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2188 | 0.280 |
Why?
|
Young Adult | 16 | 2022 | 60045 | 0.280 |
Why?
|
Motor Activity | 1 | 2017 | 2722 | 0.270 |
Why?
|
Adolescent | 20 | 2022 | 89168 | 0.270 |
Why?
|
Electric Stimulation Therapy | 1 | 2012 | 636 | 0.270 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3837 | 0.260 |
Why?
|
Female | 42 | 2024 | 396943 | 0.260 |
Why?
|
Male | 40 | 2024 | 364781 | 0.260 |
Why?
|
Treatment Outcome | 17 | 2024 | 65409 | 0.250 |
Why?
|
Photic Stimulation | 5 | 2013 | 2005 | 0.250 |
Why?
|
Primary Health Care | 2 | 2020 | 4737 | 0.250 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2013 | 3783 | 0.240 |
Why?
|
Pharmacogenetics | 3 | 2023 | 677 | 0.220 |
Why?
|
Case-Control Studies | 8 | 2018 | 22293 | 0.220 |
Why?
|
Mood Disorders | 3 | 2014 | 1128 | 0.220 |
Why?
|
Isoxazoles | 1 | 2005 | 233 | 0.210 |
Why?
|
Antipsychotic Agents | 1 | 2016 | 3077 | 0.210 |
Why?
|
Arousal | 1 | 2009 | 1182 | 0.210 |
Why?
|
Focal Adhesions | 1 | 2023 | 114 | 0.210 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1882 | 0.200 |
Why?
|
Mental Health | 1 | 2017 | 3271 | 0.200 |
Why?
|
Middle Aged | 24 | 2024 | 223418 | 0.200 |
Why?
|
Wounds and Injuries | 1 | 2014 | 2518 | 0.190 |
Why?
|
Substance-Related Disorders | 3 | 2018 | 4453 | 0.190 |
Why?
|
Disease Progression | 1 | 2018 | 13655 | 0.190 |
Why?
|
Depressive Disorder | 3 | 2018 | 3738 | 0.190 |
Why?
|
Glutamic Acid | 3 | 2013 | 1192 | 0.180 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8051 | 0.180 |
Why?
|
Endophenotypes | 1 | 2022 | 258 | 0.170 |
Why?
|
Psychomotor Performance | 3 | 2013 | 1894 | 0.170 |
Why?
|
Suicide | 2 | 2020 | 1608 | 0.160 |
Why?
|
Diffusion Tensor Imaging | 3 | 2022 | 2427 | 0.160 |
Why?
|
Personality Inventory | 3 | 2019 | 1019 | 0.150 |
Why?
|
Iatrogenic Disease | 1 | 2021 | 552 | 0.150 |
Why?
|
Pilot Projects | 3 | 2020 | 8730 | 0.150 |
Why?
|
Double-Blind Method | 5 | 2019 | 12450 | 0.140 |
Why?
|
Oxygen | 4 | 2016 | 4269 | 0.140 |
Why?
|
Midazolam | 1 | 2019 | 267 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2013 | 6320 | 0.140 |
Why?
|
Gyrus Cinguli | 3 | 2009 | 1136 | 0.130 |
Why?
|
Reward | 2 | 2015 | 987 | 0.130 |
Why?
|
Personality | 1 | 2019 | 558 | 0.130 |
Why?
|
Outpatients | 1 | 2023 | 1607 | 0.130 |
Why?
|
Arthroscopy | 1 | 2022 | 971 | 0.120 |
Why?
|
Comorbidity | 3 | 2020 | 10601 | 0.120 |
Why?
|
Putamen | 1 | 2016 | 292 | 0.120 |
Why?
|
Epilepsy | 2 | 2020 | 3324 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2228 | 0.120 |
Why?
|
Gender Identity | 1 | 2020 | 769 | 0.120 |
Why?
|
Gene Regulatory Networks | 1 | 2023 | 1755 | 0.110 |
Why?
|
International Cooperation | 2 | 2018 | 1439 | 0.110 |
Why?
|
Neostriatum | 1 | 2015 | 247 | 0.110 |
Why?
|
Neuropsychological Tests | 3 | 2020 | 7134 | 0.110 |
Why?
|
Telemedicine | 2 | 2022 | 3104 | 0.110 |
Why?
|
Anesthetics | 1 | 2019 | 525 | 0.110 |
Why?
|
Cocaine | 2 | 2011 | 960 | 0.110 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 479 | 0.100 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2018 | 578 | 0.100 |
Why?
|
Tritium | 1 | 2013 | 707 | 0.100 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 969 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2018 | 925 | 0.100 |
Why?
|
Membrane Potentials | 1 | 2016 | 1090 | 0.100 |
Why?
|
Hippocampus | 2 | 2018 | 3783 | 0.100 |
Why?
|
Behavior, Addictive | 1 | 2018 | 467 | 0.100 |
Why?
|
Circadian Rhythm | 3 | 2018 | 2585 | 0.100 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 1994 | 0.100 |
Why?
|
Registries | 2 | 2019 | 8373 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1763 | 0.100 |
Why?
|
Borderline Personality Disorder | 1 | 2018 | 775 | 0.090 |
Why?
|
Calcium Channels | 1 | 2015 | 624 | 0.090 |
Why?
|
Psychotic Disorders | 2 | 2023 | 3278 | 0.090 |
Why?
|
Aspartic Acid | 1 | 2013 | 577 | 0.090 |
Why?
|
Child | 9 | 2021 | 80863 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 921 | 0.090 |
Why?
|
Carbon Isotopes | 1 | 2011 | 459 | 0.090 |
Why?
|
Cognition | 3 | 2020 | 7066 | 0.090 |
Why?
|
Mental Health Services | 1 | 2022 | 1732 | 0.090 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12774 | 0.090 |
Why?
|
Heterozygote | 1 | 2017 | 2792 | 0.090 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2004 | 1142 | 0.080 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2011 | 298 | 0.080 |
Why?
|
Thalamus | 1 | 2016 | 1051 | 0.080 |
Why?
|
Mediodorsal Thalamic Nucleus | 1 | 2009 | 12 | 0.080 |
Why?
|
Risk-Taking | 1 | 2015 | 1041 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2016 | 1427 | 0.080 |
Why?
|
Risk | 2 | 2018 | 9642 | 0.080 |
Why?
|
Age Distribution | 1 | 2015 | 2881 | 0.080 |
Why?
|
Regression Analysis | 2 | 2018 | 6353 | 0.080 |
Why?
|
Pituitary Gland | 1 | 2011 | 634 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3771 | 0.080 |
Why?
|
Fibroblasts | 1 | 2018 | 4180 | 0.070 |
Why?
|
Bariatric Surgery | 1 | 2018 | 1007 | 0.070 |
Why?
|
Alcoholism | 1 | 2018 | 1993 | 0.070 |
Why?
|
Age of Onset | 1 | 2015 | 3342 | 0.070 |
Why?
|
Globus Pallidus | 1 | 2009 | 250 | 0.070 |
Why?
|
Dominance, Cerebral | 1 | 2009 | 624 | 0.070 |
Why?
|
Gene Expression | 1 | 2020 | 7605 | 0.070 |
Why?
|
Adolescent Behavior | 1 | 2015 | 1192 | 0.070 |
Why?
|
Aged | 8 | 2024 | 171520 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13026 | 0.070 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2007 | 92 | 0.060 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2010 | 600 | 0.060 |
Why?
|
Huntington Disease | 1 | 2012 | 1145 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14766 | 0.060 |
Why?
|
Reaction Time | 1 | 2011 | 2102 | 0.060 |
Why?
|
Diencephalon | 1 | 2004 | 54 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2018 | 1890 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 3742 | 0.060 |
Why?
|
Bayes Theorem | 1 | 2013 | 2358 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6217 | 0.060 |
Why?
|
Pindolol | 1 | 2004 | 34 | 0.060 |
Why?
|
Suicidal Ideation | 1 | 2014 | 1466 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15965 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26351 | 0.060 |
Why?
|
Reference Values | 2 | 2009 | 4941 | 0.060 |
Why?
|
Corpus Callosum | 1 | 2009 | 755 | 0.060 |
Why?
|
Visual Perception | 1 | 2012 | 1406 | 0.060 |
Why?
|
Flumazenil | 1 | 2003 | 84 | 0.060 |
Why?
|
Inpatients | 1 | 2014 | 2561 | 0.050 |
Why?
|
Seasonal Affective Disorder | 1 | 2002 | 49 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10358 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13497 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3961 | 0.050 |
Why?
|
Catecholamines | 1 | 2002 | 390 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2007 | 6242 | 0.050 |
Why?
|
Serotonin | 2 | 2004 | 1047 | 0.050 |
Why?
|
Genotype | 1 | 2015 | 13047 | 0.040 |
Why?
|
Bilirubin | 1 | 2002 | 439 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1123 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 16029 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2005 | 888 | 0.040 |
Why?
|
Receptors, GABA-A | 1 | 2003 | 626 | 0.040 |
Why?
|
Astrocytes | 1 | 2007 | 1354 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2022 | 81834 | 0.040 |
Why?
|
Phototherapy | 1 | 2002 | 369 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2004 | 1036 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2007 | 1882 | 0.040 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2018 | 89 | 0.040 |
Why?
|
Parkinson Disease | 1 | 2012 | 2891 | 0.040 |
Why?
|
Period Circadian Proteins | 1 | 2018 | 97 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2004 | 1244 | 0.040 |
Why?
|
Luminescent Measurements | 1 | 2018 | 342 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 669 | 0.030 |
Why?
|
Risk Factors | 2 | 2015 | 74915 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4861 | 0.030 |
Why?
|
Anxiety | 2 | 2021 | 4655 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18048 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5880 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6657 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3713 | 0.030 |
Why?
|
Paroxetine | 2 | 2004 | 181 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2268 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4417 | 0.020 |
Why?
|
Functional Laterality | 1 | 2018 | 2268 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1890 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2020 | 1197 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5308 | 0.020 |
Why?
|
Fluoxetine | 2 | 2004 | 735 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2195 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3484 | 0.020 |
Why?
|
Neurotransmitter Uptake Inhibitors | 1 | 2007 | 36 | 0.020 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2007 | 39 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5909 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9507 | 0.020 |
Why?
|
United States | 1 | 2015 | 73121 | 0.020 |
Why?
|
Kainic Acid | 1 | 2007 | 203 | 0.020 |
Why?
|
Dicarboxylic Acids | 1 | 2007 | 75 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4266 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2007 | 276 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54914 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2007 | 341 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 286 | 0.010 |
Why?
|
Parents | 1 | 2018 | 3596 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9504 | 0.010 |
Why?
|
Connecticut | 1 | 2004 | 365 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18478 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19041 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2007 | 1891 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 328 | 0.010 |
Why?
|
alpha-Methyltyrosine | 1 | 2002 | 6 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5367 | 0.010 |
Why?
|
Diphenhydramine | 1 | 2002 | 63 | 0.010 |
Why?
|
Occipital Lobe | 1 | 2003 | 376 | 0.010 |
Why?
|
Receptors, GABA | 1 | 2003 | 313 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 2004 | 395 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 905 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 8081 | 0.010 |
Why?
|
Neuroglia | 1 | 2007 | 961 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2004 | 1035 | 0.010 |
Why?
|
Social Behavior | 1 | 2007 | 1144 | 0.010 |
Why?
|
Tryptophan | 1 | 2002 | 483 | 0.010 |
Why?
|
Norepinephrine | 1 | 2002 | 900 | 0.010 |
Why?
|
Drug Resistance | 1 | 2004 | 1599 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2103 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41797 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2003 | 1140 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40271 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6030 | 0.010 |
Why?
|
Dopamine | 1 | 2002 | 1616 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10784 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 2731 | 0.010 |
Why?
|
Animals | 2 | 2018 | 169418 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 59680 | 0.010 |
Why?
|
Mice | 1 | 2018 | 82045 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23839 | 0.010 |
Why?
|
Veterans | 1 | 2004 | 2671 | 0.010 |
Why?
|
Infant | 1 | 2010 | 36497 | 0.000 |
Why?
|
Child, Preschool | 1 | 2010 | 42623 | 0.000 |
Why?
|